Publications:

• Oderich GS, Greiten LE.  Endovascular Repair of Thoracoabdominal Aortic Aneurysms Using on Table Physician-Modified Fenestrated and Branched Stent Grafts.  Cardiac Surgery:  Technique and Practice.  McGraw-Hill, New York
• Greiten LE, Holditch S, Aruachalam S, Miller VM.  Sex-differences in Assessment and Etiology of Heart Failure.  Journal of Cardiovascular Translational Research.  2013 Nov. 9.
• Greiten LE, McKellar SH, Rysavy J, and Schaff HV.  Effectiveness of Rivaroxaban for Thromboprophyalxis of Prosthetic Heart Valves.  European Journal of Cardiothoracic Surgery. 2013 Dec 3.
• Gifford SM, Duncan A, Greiten LE, Gloviczki P, Oderich GS, Kalra M, Flemming M, Bower, T.  The Natural History and Outcomes for Thoracic and Abdominal Penetrating Aortic Ulcers. Vascular Annual Meeting. (Abstract #1629395), Journal of Vascular Surgery.  2013.  Publication forthcoming. 
• Zhang H, Greiten LE, Zhang B, Miller JD.  Sirtuin 6 Reduces Osteogenic Signaling in Aortic Valve Interstitial Cells and Vascular Smooth Muscle Cells.  Arteriosclerosis Thrombosis and Vascular Biology.  2012:32: A366 (abstract).  Publication forthcoming.
• Greiten LE, Zhang B, Roos CM, Hagler M, Fritz-Patrick J, and Miller JD.  Sirtuin 6-Mediated Histone Deacetylation is a Critical Mediator of Vascular Function. Pre-submission.
• Greiten LE, Bose R, Sethi G, and Copeland JG.  Efficacy of Platelet Rich Plasma Gel Application to the Saphenous Vein Harvest Site made during Coronary Artery Bypass Grafting. Journal of Investigative Medicine (Abstract #26 pg S377).

Presentations:

• Podium Presentation:  "Improved Long-Term Survival with Repeat Coronary Bypass Surgery versus Percutaneous Coronary Intervention After Previous Bypass Sugery."  American Heart Association, Scientific Session.  New Orleans, LA.  November 14, 2016.
• Poster Presentation:  "Outcomes of Patients Undergoing Rib Fracture Stabilization by Severity of Pulmonary Contusion."  28th Annual Meeting of the General Thoracic Surgical Club.  Naples, FL.  March 12-15, 2015.
• Podium Presentation:  “Effectiveness of Rivaroxaban for Thromboprophylaxis of Prosthetic Heart Valves in a Porcine Heterotopic Valve Model.”  Balfour Symposium.  Mayo Clinic, Rochester MN. December 6, 2013.
• Poster Presentation:  “The Natural History and Outcomes for Thoracic and Abdominal Penetrating Aortic Ulcers.” Balfour Symposium.  Mayo Clinic, Rochester MN. December 6, 2013.
• Podium Presentation:  “The Natural History and Outcomes for Thoracic and Abdominal Penetrating Aortic Ulcers.” Minnesota Surgical Society Fall Meeting.  Alexandria, MN.  October 18, 2013.
• Podium Presentation:  “Effectiveness of Rivaroxaban for Thromboprophylaxis of Prosthetic Heart Valves in a Procine Heterotopic Valve Model.”  Minnesota Surgical Society Fall Meeting.  Alexandria, MN.  October 18, 2013.
• Poster Presentation:  “The Natural History and Outcomes for Thoracic and Abdominal Penetrating Aortic Ulcers.”  Vascular Annual Meeting.  San Francisco, CA. May 31, 2013.
• Podium Presentation:  “SIRT6 protects against angiotensin II-induced vasomotor dysfunction.”  16th Annual C. Walton Lillehei Resident Forum.  American Association of Thoracic Surgery, National Meeting, Minneapolis MN, May 2013.
• Poster Presentation:  “The Role of Sirtuin 6 in Age Related Cardiovascular Disease.”  3rd Annual Robert and Arlene Kogod Center on Aging.  Mayo Clinic, Rochester MN, November 9, 2012
• Podium Presentation:  “Sirtuin 6- mediated histone deacetylation is a critical mediator of vascular function.”  Balfour Symposium.  Mayo Clinic, Rochester MN, November 2, 2012
• Podium Presentation:  “Sirtuin 6 is a critical determinant of endothelial function in mice.”  15th Annual C. Walton Lillehei Resident Forum.  American Association of Thoracic Surgery, National Meeting, San Francisco CA, April 2012.
• Podium Presentation: “The role of sirtuin 6 in age related cardiovascular disease.”  Resident Education Day.  Mayo Clinic, February 2012.
• Podium Presentation: “Role of histone acetylation in age-related cardiovascular disease.”  Kirklin Visiting Professor Lecture, Rochester MN, October, 2011.
• Poster Presentation:  “Role of Sirtuin 6 (SIRT 6) in the regulation of valvular and vascular disease.”  Balfour Research Symposium.  Rochester MN, October, 2011
• Podium Presentation: “Role of Sirtuin 6 in age-related cardiovascular disease.”  Minnesota Surgical Society, Redwind MN, September 30, 2011.
• Podium Presentation: “Sirtuins and age-related cardiovascular disease.”  Robert and Arlene Kogod Center on Aging, Rochester MN, May 16, 2011.
• Podium Presentation: “Efficacy of Platelet Rich Plasma Gel Application to the saphenous Vein Harvest Site made during Coronary Artery Bypass Grafting.”  Western Student Medical Research Forum, Carmel CA, February 2006. 
• Poster Presentation: “Efficacy of Platelet Rich Plasma Gel Application to the saphenous Vein Harvest Site made during CABG.”  The American Federation for Medical Research, Clinical Research.  Washington DC, March 16-18, 2006.
• Podium Presentation: “Efficacy of Platelet Rich Plasma Gel Application to the saphenous Vein Harvest Site made during Coronary Artery Bypass Grafting-Interim Analysis”  Medical Student Research Program.  August 2005, Tucson AZ.